IL12A and inflammatory bowel disease: The examination of the expression levels in the target genes among the remission and flare-up phases of the IBD patients showed marked increased in the mRNA contents of IL-12A (P=0.003) (Figure 1) and IL-12B (P=0/0002) in the remission phase as compared to the flare-up period.